Contact

Publications

News

Publications

Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
November 6, 2025

Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.

Where science meets health: intelligent anti-inflammation to accelerate therapies for obesity & CKD.

Linkedin-in X-twitter

01

Our Approach

02

Our Team

03

Pipeline

04

News
Address

8 THE GREEN, SUITE 8235 DOVER DE 19901

Contact

Info@mwyngil.com

© 2026 Mwyngil Inc. All rights reserved.